Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Aliza Brown

Concepts (248)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
13
2020
515
2.470
Why?
Thrombolytic Therapy
8
2020
112
1.130
Why?
Tissue Plasminogen Activator
9
2020
109
1.090
Why?
Brain Ischemia
5
2020
162
0.980
Why?
Endarterectomy, Carotid
9
2011
62
0.850
Why?
Thrombectomy
2
2020
73
0.820
Why?
Health Services Misuse
1
2020
13
0.670
Why?
Fibrinolytic Agents
7
2020
131
0.670
Why?
Tunica Intima
8
2011
56
0.660
Why?
Time-to-Treatment
1
2020
78
0.640
Why?
Patient Transfer
1
2020
99
0.640
Why?
Homocysteine
7
2011
126
0.620
Why?
Disease Models, Animal
12
2015
1486
0.560
Why?
Pneumonia, Viral
1
2020
178
0.530
Why?
Microbubbles
3
2011
26
0.530
Why?
Emergency Service, Hospital
2
2020
524
0.530
Why?
Coronavirus Infections
1
2020
189
0.530
Why?
Carotid Arteries
6
2010
76
0.510
Why?
Emergency Medical Technicians
1
2016
10
0.510
Why?
Emergency Medical Services
1
2016
114
0.480
Why?
Fluorocarbons
4
2019
61
0.470
Why?
Ultrasonic Therapy
3
2011
30
0.470
Why?
Acetaminophen
3
2011
279
0.450
Why?
Acetylcysteine
2
2011
103
0.440
Why?
Quality Improvement
1
2016
224
0.430
Why?
Cerebral Hemorrhage
3
2015
100
0.380
Why?
Rural Population
1
2016
572
0.370
Why?
Liver Failure, Acute
1
2011
56
0.360
Why?
Intracranial Embolism
2
2012
29
0.360
Why?
Rabbits
10
2016
373
0.340
Why?
Carotid Stenosis
4
2011
66
0.290
Why?
Animals
26
2016
13507
0.270
Why?
Time Factors
11
2020
3000
0.260
Why?
Neuroprotective Agents
2
2019
101
0.260
Why?
Insulin Resistance
2
2010
278
0.250
Why?
Magnetic Resonance Imaging
2
2014
1545
0.240
Why?
Male
22
2020
26863
0.200
Why?
Platelet Aggregation Inhibitors
4
2006
213
0.200
Why?
Brain
1
2010
1325
0.190
Why?
Rats
12
2011
3203
0.180
Why?
Rats, Sprague-Dawley
9
2011
1554
0.170
Why?
United States
4
2020
5227
0.170
Why?
Hyperplasia
8
2011
98
0.170
Why?
Triage
1
2020
66
0.170
Why?
Conflict of Interest
1
2020
26
0.160
Why?
Disease Outbreaks
1
2020
123
0.160
Why?
Fabry Disease
1
2019
9
0.160
Why?
Angiography, Digital Subtraction
2
2011
27
0.160
Why?
Enzyme Replacement Therapy
1
2019
17
0.160
Why?
Carotid Artery, Common
2
2011
44
0.150
Why?
Ischemic Attack, Transient
1
2019
59
0.150
Why?
Cardiology
1
2020
101
0.150
Why?
Cerebral Angiography
3
2012
90
0.140
Why?
Humans
13
2020
52593
0.140
Why?
Cohort Studies
1
2020
1553
0.130
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
3
2004
58
0.120
Why?
Middle Aged
7
2020
13096
0.120
Why?
Infarction, Anterior Cerebral Artery
1
2015
2
0.120
Why?
Pandemics
1
2020
587
0.120
Why?
Aged
6
2020
10191
0.120
Why?
Follow-Up Studies
1
2020
2291
0.120
Why?
Female
12
2020
28262
0.120
Why?
Infarction, Middle Cerebral Artery
1
2015
40
0.120
Why?
Retrospective Studies
4
2020
6671
0.120
Why?
Ticlopidine
2
2006
72
0.110
Why?
Receptors, N-Methyl-D-Aspartate
2
2005
79
0.110
Why?
Antidotes
2
2011
27
0.110
Why?
Prospective Studies
1
2020
2457
0.110
Why?
Salivary Proteins and Peptides
2
2004
8
0.110
Why?
L-Lactate Dehydrogenase
1
2014
71
0.110
Why?
Posterior Leukoencephalopathy Syndrome
1
2014
44
0.100
Why?
Fractures, Compression
1
2013
17
0.100
Why?
Fractures, Spontaneous
1
2013
15
0.100
Why?
Models, Animal
4
2011
228
0.100
Why?
Spine
1
2013
88
0.100
Why?
Treatment Outcome
5
2019
5486
0.100
Why?
Telemedicine
1
2019
493
0.100
Why?
Expectorants
1
2011
14
0.090
Why?
Analysis of Variance
2
2011
558
0.090
Why?
Echinomycin
1
2011
6
0.090
Why?
Carotid Artery Injuries
1
2011
12
0.090
Why?
Statistics as Topic
1
2011
87
0.090
Why?
Circle of Willis
1
2011
2
0.090
Why?
Sensitivity and Specificity
2
2011
883
0.090
Why?
Cerebral Infarction
1
2011
31
0.090
Why?
Ultrasonography, Doppler, Transcranial
1
2011
20
0.090
Why?
Intracranial Hemorrhages
1
2011
41
0.090
Why?
Sinus Thrombosis, Intracranial
1
2010
16
0.090
Why?
Acarbose
1
2010
2
0.090
Why?
Receptors, Adrenergic, beta-2
1
2000
16
0.090
Why?
Indocyanine Green
1
2010
29
0.090
Why?
Analgesics, Non-Narcotic
1
2011
117
0.080
Why?
Hepatocytes
1
2011
190
0.080
Why?
Estradiol
1
2011
216
0.080
Why?
Subarachnoid Hemorrhage
1
2010
60
0.080
Why?
Trachea
1
2000
54
0.080
Why?
Ultrasonography, Interventional
1
2010
139
0.080
Why?
Adult
4
2020
14170
0.080
Why?
Radiography
1
2010
474
0.080
Why?
Arkansas
3
2019
2029
0.080
Why?
Dietary Sucrose
2
2010
14
0.070
Why?
Hypoglycemic Agents
1
2010
217
0.070
Why?
Glucocorticoids
1
2000
238
0.070
Why?
Dexamethasone
1
2000
440
0.070
Why?
Cystathionine beta-Synthase
2
2004
18
0.070
Why?
Reproducibility of Results
1
2011
1217
0.070
Why?
Ketorolac Tromethamine
1
2007
2
0.070
Why?
Myocytes, Smooth Muscle
2
2005
96
0.070
Why?
Cyclooxygenase Inhibitors
1
2007
39
0.070
Why?
Recovery of Function
2
2019
202
0.070
Why?
Cerebral Veins
1
2007
17
0.070
Why?
Mice
3
2011
5958
0.070
Why?
Drug Administration Schedule
2
2019
376
0.070
Why?
Cerebral Arteries
1
2007
30
0.070
Why?
Random Allocation
3
2015
287
0.060
Why?
Pravastatin
1
2006
18
0.060
Why?
Insulin
2
2010
484
0.060
Why?
Antineoplastic Agents
1
2014
1221
0.060
Why?
Antioxidants
1
2007
258
0.060
Why?
Constriction
1
2004
8
0.060
Why?
Liver
1
2010
1160
0.060
Why?
Smoke
1
2004
18
0.060
Why?
Platelet Aggregation
1
2005
78
0.060
Why?
Blood Platelets
2
2006
263
0.060
Why?
Muscle, Smooth, Vascular
1
2005
136
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
149
0.060
Why?
Cell Division
1
2005
288
0.060
Why?
Databases, Factual
2
2020
715
0.050
Why?
Neoplasms
1
2014
1308
0.050
Why?
Emulsions
2
2015
25
0.050
Why?
Cystathionine gamma-Lyase
1
2003
4
0.050
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.050
Why?
Postoperative Period
1
2004
172
0.050
Why?
Endothelium, Vascular
1
2005
258
0.050
Why?
Saphenous Vein
1
2004
65
0.050
Why?
Arterial Occlusive Diseases
1
2004
81
0.050
Why?
Lower Extremity
1
2004
99
0.050
Why?
Dietary Carbohydrates
1
2003
90
0.050
Why?
Oxidative Stress
1
2007
810
0.050
Why?
Dietary Fats
1
2003
129
0.050
Why?
Diet
2
2005
588
0.050
Why?
Preoperative Care
1
2004
174
0.050
Why?
Folic Acid
1
2003
136
0.050
Why?
Collagen
1
2003
213
0.050
Why?
Renal Dialysis
1
2003
191
0.050
Why?
Dose-Response Relationship, Drug
3
2011
1378
0.040
Why?
Health Care Sector
1
2020
15
0.040
Why?
Drug Industry
1
2020
40
0.040
Why?
Tomography, X-Ray Computed
2
2018
1162
0.040
Why?
Maximum Tolerated Dose
1
2019
39
0.040
Why?
alpha-Galactosidase
1
2019
9
0.040
Why?
Administration, Intravenous
1
2019
74
0.040
Why?
Disability Evaluation
1
2019
92
0.040
Why?
Multiple Myeloma
1
2013
3050
0.040
Why?
Cell Count
2
2005
144
0.040
Why?
Double-Blind Method
1
2019
718
0.030
Why?
Referral and Consultation
1
2019
292
0.030
Why?
Blotting, Western
2
2005
593
0.030
Why?
Glutamates
1
2016
21
0.030
Why?
Gene Expression Regulation
2
2011
1006
0.030
Why?
Angiography
1
2016
114
0.030
Why?
Single-Blind Method
1
2015
116
0.030
Why?
Drug Evaluation, Preclinical
1
2015
142
0.030
Why?
Infusions, Intravenous
1
2015
222
0.030
Why?
Reperfusion Injury
1
2015
72
0.030
Why?
Blood Chemical Analysis
1
2014
26
0.030
Why?
Immunohistochemistry
2
2005
984
0.020
Why?
Infusion Pumps, Implantable
1
2011
14
0.020
Why?
Angioplasty
1
2011
21
0.020
Why?
Estrogen Replacement Therapy
1
2011
28
0.020
Why?
Proliferating Cell Nuclear Antigen
1
2011
68
0.020
Why?
Hyperhomocysteinemia
1
2011
29
0.020
Why?
Liver Regeneration
1
2011
47
0.020
Why?
Jugular Veins
1
2011
32
0.020
Why?
Ovariectomy
1
2011
113
0.020
Why?
Statistics, Nonparametric
1
2011
196
0.020
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2011
62
0.020
Why?
Chi-Square Distribution
1
2011
295
0.020
Why?
Vascular Endothelial Growth Factor A
1
2011
187
0.020
Why?
Adrenergic beta-2 Receptor Agonists
1
2000
5
0.020
Why?
Ultrasonography, Doppler, Pulsed
1
2010
2
0.020
Why?
Injections, Intravenous
1
2010
135
0.020
Why?
Coloring Agents
1
2010
68
0.020
Why?
Phlebography
1
2010
55
0.020
Why?
Isoproterenol
1
2000
56
0.020
Why?
Luciferases
1
2000
50
0.020
Why?
Mice, Inbred Strains
1
2010
164
0.020
Why?
Epithelium
1
2000
65
0.020
Why?
Adrenergic beta-Agonists
1
2000
42
0.020
Why?
Alanine Transaminase
1
2010
122
0.020
Why?
Regional Blood Flow
1
2010
107
0.020
Why?
Cyclic AMP
1
2000
92
0.020
Why?
Blood Flow Velocity
1
2010
95
0.020
Why?
Propranolol
1
2000
78
0.020
Why?
Norepinephrine
1
2000
112
0.020
Why?
Epinephrine
1
2000
93
0.020
Why?
Transfection
1
2000
369
0.020
Why?
Cell Membrane
1
2000
242
0.020
Why?
Ultrasonography
1
2011
424
0.020
Why?
Transcription, Genetic
1
2000
380
0.020
Why?
DNA
1
2011
549
0.020
Why?
Cell Line
1
2000
1033
0.020
Why?
Malondialdehyde
1
2007
54
0.020
Why?
Blood Glucose
1
2010
473
0.020
Why?
Platelet Activation
1
2007
49
0.020
Why?
Triiodobenzoic Acids
1
2007
9
0.020
Why?
Glutathione
1
2007
306
0.020
Why?
Contrast Media
1
2007
175
0.020
Why?
Drug Combinations
1
2006
134
0.020
Why?
Aged, 80 and over
1
2013
3420
0.010
Why?
Dizocilpine Maleate
1
2005
14
0.010
Why?
Cholesterol
1
2006
157
0.010
Why?
Matrix Metalloproteinase 9
1
2005
87
0.010
Why?
Interleukin-1
1
2005
105
0.010
Why?
Excitatory Amino Acid Antagonists
1
2005
46
0.010
Why?
Homocystine
1
2004
8
0.010
Why?
DNA, Complementary
1
2005
131
0.010
Why?
Cell Culture Techniques
1
2005
99
0.010
Why?
Platelet Function Tests
1
2004
22
0.010
Why?
C-Reactive Protein
1
2006
152
0.010
Why?
Aorta, Thoracic
1
2005
98
0.010
Why?
Cotinine
1
2004
20
0.010
Why?
Probability
1
2004
173
0.010
Why?
Reference Values
1
2004
313
0.010
Why?
RNA
1
2005
172
0.010
Why?
Biopsy, Needle
1
2004
182
0.010
Why?
Cell Movement
1
2005
276
0.010
Why?
Ultrasonography, Doppler, Duplex
1
2004
21
0.010
Why?
Severity of Illness Index
1
2007
1037
0.010
Why?
Arginine
1
2005
182
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
582
0.010
Why?
Platelet Adhesiveness
1
2003
14
0.010
Why?
Nitric Oxide
1
2005
244
0.010
Why?
Elastin
1
2003
23
0.010
Why?
Polytetrafluoroethylene
1
2003
33
0.010
Why?
Signal Transduction
1
2000
1714
0.010
Why?
Young Adult
1
2013
4337
0.010
Why?
Anastomosis, Surgical
1
2003
70
0.010
Why?
Vascular Patency
1
2003
82
0.010
Why?
Dogs
1
2003
183
0.010
Why?
Extracellular Matrix
1
2003
112
0.010
Why?
Graft Occlusion, Vascular
1
2003
78
0.010
Why?
Gene Expression
1
2005
623
0.010
Why?
RNA, Messenger
1
2005
1139
0.010
Why?
Adolescent
1
2013
6737
0.010
Why?
Cells, Cultured
1
2005
1588
0.010
Why?
Cell Proliferation
1
2005
1029
0.010
Why?
Models, Biological
1
2003
741
0.010
Why?
Brown's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description